“The Impact of Tralokinumab on Quality of Life and School in Patients Aged 12-17 With Atopic Dermatitis: Results from the Phase 3 ECZTRA 6 Trial”. 2023. SKIN The Journal of Cutaneous Medicine 7 (2): s139. https://doi.org/10.25251/skin.7.supp.139.